Abstract
Background: Capsaicin (CPS) is a highly selective agonist of the transient receptor potential vanilloid type 1 (TRPV1) with a nanomolar affinity. High doses or prolonged exposure to CPS induces TRPV1 defunctionalization and, although this effect is currently used for the treatment of thermal hyperalgesia in chronic pain conditions, it is responsible of detrimental effects, such as denervation of sensory fibers. The aim of the present study was to formulate CPS loaded lipid nanocarriers (CPS-LN) in order to optimize CPS release, thus preventing TRPV1 internalization and degradation. Methods: CPS-LNs were formulated and characterized by in vitro studies. The activation of TRPV1 receptors after CPS-LN administration was evaluated by measuring spontaneous pain that was induced by local injection into the plantar surface of the mouse hind-paw. Moreover, the expression of TRPV1 in the skin was evaluated by western blot analysis in CPS-LN injected mice and then compared to a standard CPS solution (CPS-STD). Results: CPS inclusion in LN induced a lower pain response when compared to CPS-STD; further, it prevented TRPV1 down-regulation in the skin, while CPS-STD induced a significant reduction of TRPV1 expression. Conclusions: Drug encapsulation in lipid nanoparticles produced an optimization of CPS release, thus reducing mice pain behavior and avoiding the effects that are caused by TRPV1 defunctionalization related to a prolonged activation of this receptor.
Highlights
Capsaicin (CPS), which is the pungent ingredient of hot peppers, is a highly selective agonist of the transient receptor potential vanilloid type 1 (TRPV1) with nanomolar affinity [1]
This study provides important evidence regarding the efficacy of lipid nanocarrier (LN) as carriers for CPS administration
CPS loaded lipid nanocarriers (CPS-LN) were formulated by using the solvent injection method, which appeared to be suitable for LN preparation
Summary
Capsaicin (CPS), which is the pungent ingredient of hot peppers, is a highly selective agonist of the transient receptor potential vanilloid type 1 (TRPV1) with nanomolar affinity [1]. Within the peripheral nervous system, the TRPV1 receptors are located in sensory ganglia and in small sensory C and Aδ fibers [5,8], representing a promising target for the modulation of pain sensitivity [9,10]. TRPV1 receptors that are expressed in nociceptive sensory nerves (C and Aδ fibers) are targeted by topical capsaicin formulations, such as creams, lotions, or patches used for the management of neuropathic pain [12,13]. High doses or prolonged exposure to CPS induces TRPV1 defunctionalization and, this effect is currently used for the treatment of thermal hyperalgesia in chronic pain conditions, it is responsible of detrimental effects, such as denervation of sensory fibers. Conclusions: Drug encapsulation in lipid nanoparticles produced an optimization of CPS release, reducing mice pain behavior and avoiding the effects that are caused by TRPV1 defunctionalization related to a prolonged activation of this receptor
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
